The most frequent comorbidities at patients with the chronic obstructive pulmonary disease

Biljana Krdžić ,
Biljana Krdžić
Jelena Milovanović ,
Jelena Milovanović
Maja Šipić ,
Maja Šipić
Zlatica Petković ,
Zlatica Petković
Biserka Nedeljković
Biserka Nedeljković

Published: 01.12.2017.

Volume 47, Issue 3 (2018)

pp. 47-51;

https://doi.org/10.5937/pramed1804047k

Abstract

Chronic obstructive pulmonary disease (COPD) is a disease with periods of remission and exacerbation and consequential defect of the pulmonary function. It is estimated that around 3 million people die from it annually and predicted that until 2030 the number of deaths will be up to 6 million per year. According to the reports of the World Health Organization and Global initiative for chronic obstructive lung disease (GOLD) it is predicted that COPD in the next decade will be the third leading cause of death in the world.[ 1, 2 ] It is characterized by limited air flow in the breathing pathways which is not completely reversible to therapy. Since there are systemic inflammations at COPD, the mechanisms of the processes have consequences outside the lungs also. Comorbidities are frequent at patients with the Chronic obstructive lung disease and they affect the disease prognosis substantially. The most common comorbidities are cardiovascular diseases, metabolic syndrome, diabetes, anemia, osteoporosis, anxiety and depression, pulmonary embolism.

Keywords

References

1.
Hoeper MM, Barberà JA, Channick RN, Hassoun PM, Lang IM, Manes A, et al. Diagnosis, Assessment, and Treatment of Non-Pulmonary Arterial Hypertension Pulmonary Hypertension. Journal of the American College of Cardiology. 2009;54(1):S85–96.
2.
Krdžić B, Milovanović J, Šipić M, Nedeljković B, Petkovic Z, Pajovic S. Hronična opstruktivna bolest pluća i komorbiditet diabetes mellitus,XVII Kongres Udruženja Internista Srbije sa međ.učeš. 2017;
3.
Baker EH. Hyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary disease. Thorax. 2006;61(4):284–9.
4.
Küpeli E, Ulubay G, Ulasli SS, Sahin T, Erayman Z, Gürsoy A. Metabolic Syndrome is associated with increased risk of acute exacerbation of COPD: a preliminary study. Endocrine. 2010;38(1):76–82.
5.
Suissa S, Kezouh A, Ernst P. Inhaled Corticosteroids and the Risks of Diabetes Onset and Progression. The American Journal of Medicine. 2010;123(11):1001–6.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by